214 related articles for article (PubMed ID: 30843886)
1. PTHrP targets HDAC4 and HDAC5 to repress chondrocyte hypertrophy.
Nishimori S; Lai F; Shiraishi M; Kobayashi T; Kozhemyakina E; Yao TP; Lassar AB; Kronenberg HM
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843886
[TBL] [Abstract][Full Text] [Related]
2. PTHrP targets salt-inducible kinases, HDAC4 and HDAC5, to repress chondrocyte hypertrophy in the growth plate.
Nishimori S; Wein MN; Kronenberg HM
Bone; 2021 Jan; 142():115709. PubMed ID: 33148508
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-140 Provides Robustness to the Regulation of Hypertrophic Chondrocyte Differentiation by the PTHrP-HDAC4 Pathway.
Papaioannou G; Mirzamohammadi F; Lisse TS; Nishimori S; Wein MN; Kobayashi T
J Bone Miner Res; 2015 Jun; 30(6):1044-52. PubMed ID: 25529628
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway.
Kozhemyakina E; Cohen T; Yao TP; Lassar AB
Mol Cell Biol; 2009 Nov; 29(21):5751-62. PubMed ID: 19704004
[TBL] [Abstract][Full Text] [Related]
5. Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes.
Correa D; Hesse E; Seriwatanachai D; Kiviranta R; Saito H; Yamana K; Neff L; Atfi A; Coillard L; Sitara D; Maeda Y; Warming S; Jenkins NA; Copeland NG; Horne WC; Lanske B; Baron R
Dev Cell; 2010 Oct; 19(4):533-46. PubMed ID: 20951345
[TBL] [Abstract][Full Text] [Related]
6. PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation.
Zhang M; Xie R; Hou W; Wang B; Shen R; Wang X; Wang Q; Zhu T; Jonason JH; Chen D
J Cell Sci; 2009 May; 122(Pt 9):1382-9. PubMed ID: 19351720
[TBL] [Abstract][Full Text] [Related]
7. A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes.
Provot S; Nachtrab G; Paruch J; Chen AP; Silva A; Kronenberg HM
Mol Cell Biol; 2008 Jan; 28(1):344-57. PubMed ID: 17967876
[TBL] [Abstract][Full Text] [Related]
8. PTH/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways.
Guo J; Chung UI; Yang D; Karsenty G; Bringhurst FR; Kronenberg HM
Dev Biol; 2006 Apr; 292(1):116-28. PubMed ID: 16476422
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-381 Regulates Chondrocyte Hypertrophy by Inhibiting Histone Deacetylase 4 Expression.
Chen W; Sheng P; Huang Z; Meng F; Kang Y; Huang G; Zhang Z; Liao W; Zhang Z
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563877
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1 regulates chondrocyte phenotype by repressing histone deacetylase 4 during growth plate development.
Li P; Wei X; Guan Y; Chen Q; Zhao T; Sun C; Wei L
FASEB J; 2014 Sep; 28(9):3930-41. PubMed ID: 24858276
[TBL] [Abstract][Full Text] [Related]
11. Subcellular relocation of histone deacetylase 4 regulates growth plate chondrocyte differentiation through Ca2+/calmodulin-dependent kinase IV.
Guan Y; Chen Q; Yang X; Haines P; Pei M; Terek R; Wei X; Zhao T; Wei L
Am J Physiol Cell Physiol; 2012 Jul; 303(1):C33-40. PubMed ID: 22442139
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.
Vega RB; Matsuda K; Oh J; Barbosa AC; Yang X; Meadows E; McAnally J; Pomajzl C; Shelton JM; Richardson JA; Karsenty G; Olson EN
Cell; 2004 Nov; 119(4):555-66. PubMed ID: 15537544
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway.
Li TF; Dong Y; Ionescu AM; Rosier RN; Zuscik MJ; Schwarz EM; O'Keefe RJ; Drissi H
Exp Cell Res; 2004 Sep; 299(1):128-36. PubMed ID: 15302580
[TBL] [Abstract][Full Text] [Related]
14. XBP1S associates with RUNX2 and regulates chondrocyte hypertrophy.
Liu Y; Zhou J; Zhao W; Li X; Jiang R; Liu C; Guo FJ
J Biol Chem; 2012 Oct; 287(41):34500-13. PubMed ID: 22865880
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5.
He T; Huang J; Chen L; Han G; Stanmore D; Krebs-Haupenthal J; Avkiran M; Hagenmüller M; Backs J
J Mol Cell Cardiol; 2020 Aug; 145():88-98. PubMed ID: 32485181
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 4 deletion results in abnormal chondrocyte hypertrophy and premature ossification from collagen type 2α1‑expressing cells.
Du G; Xiang C; Sang X; Wang X; Shi Y; Wang N; Wang S; Li P; Wei X; Zhang M; Gao L; Zhan H; Wei L
Mol Med Rep; 2020 Nov; 22(5):4031-4040. PubMed ID: 33000215
[TBL] [Abstract][Full Text] [Related]
17. PTHrP promotes development of mouse preimplantation embryos through the AKT/cyclin D1 pathway and nuclear translocation of HDAC4.
Li YY; Guo L; Li H; Lei WL; Fan LH; Ouyang YC; Hou Y; Wang ZB; Sun QY; Lu SS; Han Z
J Cell Physiol; 2021 Oct; 236(10):7001-7013. PubMed ID: 33724469
[TBL] [Abstract][Full Text] [Related]
18. Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy.
Mak KK; Kronenberg HM; Chuang PT; Mackem S; Yang Y
Development; 2008 Jun; 135(11):1947-56. PubMed ID: 18434416
[TBL] [Abstract][Full Text] [Related]
19. [Bone and calcium update; bone research update. Molecular mechanisms regulating chondrocyte differentiation and hypertrophy].
Tsumaki N
Clin Calcium; 2011 Dec; 21(12):113-20. PubMed ID: 22133831
[TBL] [Abstract][Full Text] [Related]
20. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones.
Huang W; Chung UI; Kronenberg HM; de Crombrugghe B
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):160-5. PubMed ID: 11120880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
